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The burden of mental disorders: a comparison
of methods between the Australian burden
of disease studies and the Global Burden
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The national and Victorian burden of disease studies in Australia set out to examine critically the methods used in the
Global Burden of Disease study to estimate the burden of mental disorders. The main differences include the use of a
different set of disability weights allowing estimates in greater detail by level of severity, adjustments for comorbidity
between mental disorders, a greater number of mental disorders measured, and modelling of substance use disorders,
anxiety disorders and bipolar disorder as chronic conditions. Uniform age-weighting in the Australian studies produces
considerably lower estimates of the burden due to mental disorders in comparison with age-weighted disability-
adjusted life years. A lack of follow-up data on people with mental disorders who are identified in cross-sectional
surveys poses the greatest challenge in determining the burden of mental disorders more accurately.
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The prominent position of mental disorders, particu-
larly depression, as a cause of disease burden is awidely
quoted result of the Global Burden of Disease (GBD)
study (1–5). However, there has been little discussion
of the methods used to estimate the mental health
burden at either the global or national level. The general
debate about the use of the disability-adjusted life year
(DALY) as a summary measure of population health
has largely concentrated on the underlying assump-
tions of age-weighting and discounting and the
relevance of burden of disease measurements to
policy-making (6–11).
One report has challenged the severity weights
for mental disorders used in the GBD study.
Findings from a small community sample in New
South Wales, Australia, led to a cautious conclusion
that the GBD study may have overestimated the
disability weights (DWs) for depression and sub-
stance disorders, while underestimating the level of
disability associated with anxiety disorders (12).
However, the epidemiological assumptions that fed
into the GBD study’s calculation of the burden of
mental disorders have not been scrutinized in the
literature. Only three of the intended ten volumes in
the Global Burden of Disease and Injury Series have been
published to date (13–15); and a description of
methods used in calculating the burden of mental
disorders has not yet appeared. The only epidemio-
logical information is in vol. 2 of the series, detailing
for each disease andworld region the age-specific and
sex-specific values of incidence, prevalence, average
duration and mortality.
As part of the two recent burden of disease
studies in Australia, an effort was made to examine
critically the GBD estimates for mental disorders, to
improve the methods and to apply them to the most
appropriate information on the epidemiology of
mental disorders in the country. The results of the
national Australian study conducted by theAustralian
Institute of Health and Welfare and of an analysis of
the burden of disease in Victoria carried out by the
state’s Department of Human Services are available
as printed reports and on the internet (16–19). The
two project teams worked closely together and
shared methods and analyses.
The methods used to estimate the burden of
mental disorder in Australia are discussed below, and
departures from those of the GBD study are
identified and justified. The consequences are
described and discussed of the methodological
changes on the estimates for the state of Victoria
and the results are compared with those of the GBD
estimates for the Established Market Economy
(EME) region. Although burden was estimated for
dementia and other neurological conditions in the
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Australian studies, these conditions were included in
a separate category for nervous system disorders and
they are not discussed here.
Methods
The disability-adjusted life year
Summary measures of population health combine
information on mortality and non-fatal health out-
comes to describe population health in a single
number. The DALY was designed to provide a
common measure for fatal and non-fatal health
outcomes, to allow estimates of health impact to be
mapped to causes, and to enable common values and
health standards to be applied to all regions of the
world (13).
DALYs for a disease are the sum of the years of
life lost because of premature mortality in the
population and the years lost because of disability
for incident cases of the health condition in question.
The DALY is a health gap measure that extends the
concept of potential years of life lost because of
premature death to include equivalent years of
healthy life lost in states of less than full health,
broadly termed disability (20).
TheAustralian burden of disease studies depart
from the general methodology used in the GBD
study in the following key areas.
. The GBD study used a standard life table (West
level 26) with a life expectancy at birth of
82.5 years for women and 80 years for men,
whereas the Australian studies used the Australian
cohort life expectancy (taking declining mortality
trends into account) for 1996. This resulted in a
life expectancy at birth of 85.7 years for women
and 81.5 years for men.
. In theGBDstudy,DALYswere discounted at 3%
and age-weighted. In the Australian studies,
DALYs were discounted but were not age-
weighted. Age-weighting is intended to capture a
greater social responsibility in young and mid-
adult life for the very young and old. Age-
weighting was not used in the Australian studies
because it is perceived as inequitable by some
people and because the GBD sensitivity analyses
showed that it did not essentially change the
overall estimates of burden (13).
. In addition toDWs developed for theGBD study,
the Australian studies used those developed by
Dutch researchers (21, 22) for many conditions
because of their greater detail and their focus on
the most common disabilities found in countries
of low mortality.
. The GBD study did not account for the
occurrence of comorbid health states, whereas
the Australian studies made adjustments for the
effects of comorbidity between highly prevalent
physical conditions, between mental disorders,
and between injuries.
. The Australian studies included a wider range of
disease and injury categories than the GBD study
and provided a more detailed age breakdown of
the burden of disease.
Data sources
Apart from deaths associated with drug overdoses
and, to a lesser extent, alcohol dependence, the
number of deaths in Australia attributed to mental
disorders is small. We included as heroin deaths a
substantial number of deaths coded under accidental
poisoning due to opioids in the International
Classification of Diseases, ninth revision (ICD-9).
The estimation of the disability associated with
mental disorders requires information on the
incidence, average duration, and severity of each
disease and its sequelae. The incidence of mental
disorders is rarely measured; surveys tend to report
one-year prevalence (the number of people who
experienced relevant symptoms at any time during
the preceding 12 months). To derive the incidence,
we made extensive use of the DisMod software
package developed byHarvardUniversity to examine
the consistency between estimates of incidence,
prevalence, duration and mortality (23).
The data sources are summarized inTable 1.The
main source of prevalence data for adults was the
National Mental Health and Wellbeing Survey (MHS)
of 1997 (24), in which information was collected on
symptoms experienced in the preceding 12 months,
1 month, and 2 weeks for a representative sample of
10 560 adults. A computerized version of the
Composite International Diagnostic Interview was
used in this work. Interviews were completed for 78%
of the individuals approached. The unit record data of
the survey contained information on the prevalence of
mental disorders by ICD-10 andDSM-IV (Diagnostic
and Statistical Manual of Mental Disorders) categories
as well as a number of measures of disability, namely
the abbreviated Short Form (SF-12), the General
Health Questionnaire (GHQ), the Brief Disability
Questionnaire (BDQ) and the Kessler psychological
distress scale. We used the ICD-10 diagnoses for
consistency with our other disease categories which
were largely based on ICD-9 categories. The only
exception was post-traumatic stress disorder (PTSD),
for which we used the DSM-IV diagnosis, because the
ICD-10 criteria were too broad and would have
resulted in overestimation due to misclassification of
other anxiety disorders (25).One of themodules of the
Composite International Diagnostic Interview on
mania was omitted from the survey, and this meant
that estimates of bipolar disorder were inaccurate.
Instead, we relied on estimates from international
epidemiological studies (26).
Initially, we built our estimates of schizophre-
nia on overseas data as well (27). The results of the
Low Prevalence Disorders substudy of the MHS
showed a prevalence of psychotic disorders which
was similar to our initial estimates (28). The exclusion
of institutionalized patients from the MHS sample
was only important for these low-prevalence condi-
tions, for which we relied on other data sources.
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We based our estimates of heroin dependence
and harmful use (5 per 1000 persons aged 15–
44 years) on the numbers of heroin users enrolled in
methadone programmes together with expert esti-
mates of the proportion of dependent users reached
by these programmes. We checked the resulting
estimates for consistency with prevalence data from
the National Drug Strategy Household Survey of
1998, making allowance for underreporting and for
heroin users who would not be captured in a
household sample (29).
Severity
The Dutch study (21, 22) provided weights for three
levels of severity for most of the mental disorders.
Because of the large size of the mental health burden
we felt it desirable to use Australian information on
severity distributions together with these weights to
obtain more accurate estimates of burden. In using a
single overall DW for the spectrum of severity of a
disease, as in theGBD study, a severity distribution is
assumed and judgement of that implicit distribution
becomes part of the DW estimation task.
The use of the Dutch weights required the
matching of Australian epidemiological data to the
severity levels defined in the Dutch study. Where the
level of severity was available, as with the three levels
of severity of ICD-10 diagnoses of depression and
panic disorder in the MHS, local mental health
experts doubted whether the diagnostic categories
were representative of the actual level of severity of
disability.
We used information from the SF-12 for each
respondent in order to classify the conditions in the
MHS in the mild, moderate and severe categories
defined in the Dutch DW study, which derived DWs
using EuroQol 5D+ (EQ5D+) descriptions for each
of the health states valued. The EQ5D+ is an
extended version of the EuroQol health measure-
ment instrument with an additional domain of
cognitive functioning. The EQ5D+ descriptions of
the six anxiety disorders in adults distinguish mild/
moderate from severe mostly in the third domain of
usual activities and the fifth domain of anxiety/
depression with a score of 2 for mild/moderate and 3
for severe. Similarly, harmful alcohol use (with a score
of 2) differs from alcohol dependence (with a score of
3) in the usual activities domain. The difference
between mild, moderate and severe depression
involves further domains but it has the same split
between mild/moderate and severe on the usual
activities and anxiety/depression domains.
We thus mapped responses to three questions
(B6, B7 andB12, relating to usual activities) in the SF-
12 to the three levels of the EuroQol usual activities
domain. Similarly, we mapped responses to three
other questions (B9, B10 and B11, relating to anxiety,
depression and energy level) in the SF-12 to the three
levels of the EuroQol anxiety/depression domain.
This enabled us to categorize MHS respondents in
accordance with the EuroQol levels for usual
activities and anxiety/depression and hence with
the severity categories for the DWs.
In order to validate this method of determining
severity we examined how it compared with the way
the ICD-10 classified depression into mild, moderate
and severe levels. This involved comparing the scores
of all other instruments used in the MHS, each of
which, in its limited way, describes the severity of
disability, as follows: the mental and physical
Table 1. Data sources used in Australian burden of disease studies to estimate the incidence
and/or prevalence of mental disorders
Data source Mental disorder
National Mental Health and
Wellbeing Survey, 1997 (24)
Anxiety disorders (panic disorder, agoraphobia, social phobia, generalized anxiety
disorder, obsessive–compulsive disorder)
Depression (major depressive episode and dysthymia)
Schizophrenia (27)
Most substance abuse (alcohol, cannabis, sedative and stimulant drug dependence or
harmful use)
Borderline personality disorder
National Drug Strategy Household
Survey, 1998 (29)





Eating disorders (anorexia and bulimia) (30, 31)
Childhood disorders (attention-deficit hyperactivity disorder, autism and Asperger
syndrome) (32–35)
Depression and separation anxiety disorder in childhood (29)
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component score of SF-12 (MCS and PCS, with the
latter not expected to be much affected by mental
disorders); the overall score and Likert scores of the
GHQ; reported days out of role from the BDQ, the
main BDQ score; the mental outcome study score of
the BDQ; the WHO score of the BDQ; and the
Kessler psychological distress scale. As these instru-
ments refer to the preceding four weeks, we based
our comparisons of scores on those reporting
symptoms of depression in this period only. As
shown in Table 2, the classification system based on
the SF-12 resulted in larger differentials for the
average disability score (in the expected direction) as
measured by each of the other disability instruments.
This suggested that our classification system was
better at discerning different levels of severity in
depression and supported our use of this classifica-
tion system across the conditions for which we
derived estimates from the MHS.
Comorbidity
We derived prevalence estimates from the MHS for
six anxiety disorders, six substance use disorders,
borderline personality disorder, major depressive
episodes and dysthymia. Comorbidity between these
mental disorders was very common; the prevalence
in Australia of people with one of them being 17.8%,
35% of whom had two or more diagnoses. At the
level of individual diagnoses, the proportion of
persons with comorbid conditions was even higher.
For example, of the people with a current diagnosis of
major depression, 61% had at least one other
concurrent diagnosis. Comorbidity with anxiety
disorders was common, occurring in a third of
people with depression. Comorbidity in people with
borderline personality disorder was even more
frequent (94%). Depression, anxiety disorder and
substance use disorder occurred in 62%, 48% and
52%, respectively, of people with borderline person-
ality disorder.
Counting each of these disorders as a separate
episode could result in attributing disability in one
person in excess of a DW of 1 — the equivalent of
being dead! In order to avoid overestimation of
burden, we shared comorbidity between anxiety
disorders, affective disorders, borderline personality
disorder, and alcohol and drug dependence equally so
that a person with two ormore disorders was partially
counted in each category. On the advice of mental
health experts, 75% of comorbidity with harmful
alcohol use was attributed to the relevant other
mental disorder and 25% was attributed to harmful
alcohol use, whereas 50% of comorbidity between
anxiety and affective disorders was attributed to each
category, whereas comorbidity between all other
disorders was attributed equally between categories.
Because we captured the level of severity
separately our estimates took into account that people
with multiple diagnoses were likely to have greater
severity than people with only a single diagnosis.
Duration
It is argued that dysthymia and major depressive
disorder are part of the same disease entity, as people
with dysthymia frequently develop superimposed
major depressive episodes and the symptomatic
course of major depression commonly changes
between levels of severity (30–32). Modelling major
depression and dysthymia as one disease proves very
difficult because of the heterogeneity of the course of
the disease: some people have only one episode,
some are continuously depressed for a long time, and
the majority have multiple episodes that vary in
frequency. We therefore decided to model major
depression as episodes and to model dysthymia
separately. We added the years lost due to disability
(YLD) of major depression and dysthymia to give
total YLD for depression.
We derived estimates of the average duration
of major depressive episodes from the one-year
prevalence (symptomatic at some time during the
preceding 12months) and point prevalence (sympto-
matic in the preceding two weeks) as follows:
One-year prevalence = point prevalence652weeks + average duration
average duration
This gave average durations of 38.2 weeks and
24.9 weeks for males and females, respectively. The
Table 2. Comparison of ICD-10 classification of severity of depression and classification based on SF-12
with scores from multiple instruments
Instrument ICD-10 classification SF-12 based classification
Mild Moderate Severe Mild Moderate Severe
SF-12 MCS 46.0 34.1 29.8 46.4 30.9 21.6
SF-12 PCS 47.9 46.5 44.2 50.3 44.7 42.1
GHQ score 3.0 5.2 5.5 2.9 5.2 7.0
GHQ Likert score 13.5 17.4 18.1 13.6 17.4 20.9
BDQ — days out of role 4.8 4.8 9.1 1.6 6.8 12.8
BDQ main score 1.7 1.8 2.2 1.4 2.0 2.4
BDQ MOS score 4.2 4.5 6.1 2.9 5.7 6.8
BDQ WHO score 5.9 6.3 9.1 4.0 8.3 10.2
Kessler psychological distress scale 40.1 35.3 30.4 39.0 33.9 27.3
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literature suggests that the mean duration of both
initial and recurrent episodes of major depression is
consistent at 20 weeks (26, 33). Our higher estimate
may be attributable to recall bias of those with
symptoms of major depression in the preceding year
who did not have current symptoms. Having no
evidence to support or reject this hypothesis we used
the estimates of duration calculated above.
The overall YLD estimates are not very
sensitive to the assumed duration, as a shorter
estimate of duration leads to a higher estimate of
incidence derived from the same observed preva-
lence, and the total YLD values are proportional to
incidence multiplied by average duration. In fact, a
20-week duration for depressive episodes resulted in
almost identical estimates of YLD, although there
was a moderate shift in the age distribution from
younger adults to older age groups. We used a
remission rate of 0.124 in our DisMod model for
dysthymia based on a reported remission in 58% of
subjects during seven years of follow-up (31). From
young adults to older ages the modelled average
duration ranged from 8.0 to 3.8 years.
The literature on anxiety disorders (34, 35),
obsessive–compulsive disorder (OCD) (36) and
PTSD (37, 38) suggests that these disorders generally
run a chronic course with periods of remission and
relapse. This contrasts with the relatively short
durations estimated in the GBD study of 0.75, 1.6
and 2.5 years for panic disorder, OCD and PTSD,
respectively. To account for asymptomatic periods
during the course of these chronic conditions we
adjusted our durations by the ratio of point
prevalence and one-year prevalence.
In our DisMod models for substance use
disorders we assumed age-specific remission rates
and incidences that were consistent with the
observed large age differences in prevalence. This
led to duration estimates of 2–5 years for harmful
alcohol use, 3–7 years for alcohol dependence,
5–17 years for heroin dependence, and 3–4 years for
marijuana, sedative and stimulant dependence. The
DisModmodels for alcohol dependence and harmful
use included a twofold increased risk of death,
resulting in a number of deaths amounting to about
60% of all those attributed to alcohol in our risk
factor calculations. We accepted this as plausible,
since not all deaths attributed to alcohol occur in
people who qualify for a diagnosis of substance use
disorder. For harmful alcohol use and dependence on
marijuana, sedatives and stimulants we used the same
method of adjustment to account for asymptomatic
periods as described above for anxiety disorders. This
method cannot be applied to alcohol dependence, as
the definition assumes a chronic unremitting state.
However, local alcohol experts did not believe that
the large numbers of people identified with alcohol
dependence, particularly at younger ages, all experi-
enced disability for the duration of the condition. We
therefore adjusted our YLD calculations, assuming
that the 47–60% in males and 16–53% in females,
depending on age, who reported higher scores on the
SF–12 than the population average, represented an
equivalent to the asymptomatic periods estimated for
anxiety disorders.
We estimated durations of 4–6 years for
borderline personality disorder. This may seem short
for a personality disorder but there is no credible
alternative set of incidence and remission estimates
that can bematched to the observedMHS prevalence
figures using DisMod.
Schizophrenia was modelled as a lifelong
condition that generally starts in young adulthood
and has an elevated risk of dying based on
standardized mortality ratios (SMRs) of 154 in males
and 162 in females in the United Kingdom (39).
Disability weights
For most mental disorders we used the Dutch DWs
(Table 3). The DWs for drug dependence disorders,
manic episodes in bipolar disorder and borderline
personality disorder were extrapolated by panels of
local experts in the same way as the GBD study’s
expert panel derived weights for most conditions
after anchoring weights for 22 indicator conditions.
The weight for schizophrenia is a compound of 30%
for the untreated weight and 70% for the treated
weight from the GBD study, reflecting the average
time spent in psychosis reported from a number of
industrialized countries in the International Pilot
Study of Schizophrenia (40).
Comparisons with estimates
from the GBD study
In order to make meaningful comparisons with the
results of the GBD study for the EME region, we
recalculated our results with age-weighting and
applied the same standard model life table for years
of life lost (YLL). All comparisons are presented as
rates of DALYs per 1000 population age-standard-
ized to the 1990 EME population.
Results
According to Australian reports based on non-age-
weighted DALYs, mental illness contributed 13.2%
of the total disease burden in Victoria and 13.3% of
that in the country as a whole in 1996 (16, 19). Only
6% of the mental illness burden was attributable to
mortality, mostly involving fatal outcomes associated
with substance use disorders. Affective, anxiety and
substance use disorders together accounted for four-
fifths of the overall burden attributable to mental
illness (Fig. 1). For men, depression was the eighth
leading cause of overall burden, while alcohol and
drug use disorders were the thirteenth and fifteenth,
respectively. For women, depression was the fifth
leading cause of overall burden, while generalized
anxiety disorder and alcohol use disorder were the
twelfth and seventeenth, respectively.
Adding the age-weighting of the GBD study to
the results for Victoria gave considerably more
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prominence to mental disorders. They thus became
the largest group of conditions, contributing 20.7%
to the burden of disease. This was very similar to the
estimate of the GBD study for EMEs, in which
mental disorders other than dementia accounted for
19.5% of the total burden of disease. With age-
weighting, depression became the leading cause of
DALYs for women and the second cause for men in
Victoria. Alcohol dependence in men and women
and drug dependence in men entered the top ten,
while generalized anxiety disorder, social phobia and
bipolar disorder ranked among the top twenty
conditions for both men and women; eating
disorders and drug dependence also entered the top
twenty for women.
Notwithstanding the close agreement on the
total size of the mental health burden, there were
substantial differences between the estimates for
Victoria and those of the GBD study for EME
countries in respect of particular disorders (Table 4).
These differences are the result of variations in
estimates for one ormore of theYLDparameters (i.e.
incidence, duration and DWs) for most mental
illnesses (Table 5).
Two main factors explain most of the
differences. Firstly, the occurrence of the disease,
i.e. its prevalence, may have differed between
Australia and the EMEs. It should be noted that
almost all estimates were derived from prevalence
data. The prevalence estimates for Victoria (Table 5)
Table 3. Comparison of disability weights (DWs) for mental disorders used in the Australian burden
of disease studies and the Global Burden of Disease study
Disease category GBD Australian Comments on Australian DWs
DWa DWb
Substance use disorders
Alcohol dependence 0.18 0.07–0.18 Dutch weights (0.11–0.55)
Drug use 0.25




Anxiety disorders Range of Dutch weightsc
Panic disorder 0.15 0.21–0.27 0.11–0.69
Obsessive–compulsive disorder 0.12 0.20–0.28 0.17–0.60
Post-traumatic stress disorder 0.11 0.14–0.15 0.13–0.51
Agoraphobia 0.14–0.16 0.11–0.55
Social phobia 0.18–0.21 0.17–0.59
Generalized anxiety disorder 0.22–0.23 0.17–0.60
Affective disorders Range of Dutch weights
Major depressive episodes 0.50 0.37–0.41 0.14–0.76
Dysthymia 0.33–0.38
Bipolar disorder 0.51 0.18 Composite of locally derived weight for
mania (0.50), Dutch moderate
depression weight for depressive
episodes (0.34) and Dutch mild
depression weight for time between
episodes (0.14)
Schizophrenia 0.41 0.43 Composite of 30% untreated and 70%
treated GBD DWs
Borderline personality disorder 0.54 Locally derived weight
Eating disorders 0.28 Dutch weight
Attention deficit/hyperactivity disorder 0.02–0.15 Dutch weights for mild and moderate
(ADHD) ADHD
Autism 0.55 Dutch weight
a Calculated from treated and untreated DWs together with proportion assumed treated. For further details on GBD weights see ref. 13.
b DW range indicates variations by age and sex in distribution by severity level.
c For further details, refer to Dutch disability weights study (21, 22).
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included the downward adjustment for comorbidity
between mental disorders. Secondly, the disease
models may have differed, particularly in respect of
the assumptions on the distribution of severity, DWs
and average duration.
Our estimates of the burden of alcohol
dependence and harmful use in men were less than
half those for the EMEs. To some extent this
reflected a lower prevalence in Victoria (partly
attributable to the adjustment for comorbidity) but
the main influence was the downward adjustment of
the average level of disability, on the assumption that
the proportion of survey respondents not reporting
disability on six key questions of the SF-12 reflected
symptom-free periods during the course of illness.
Despite taking a similar prevalence of major
depression as a starting point and including dysthy-
mia, we estimated a lower burden from depression in
Victoria. This was largely because of the use of lower
DWs. Our YLD estimates for bipolar disorder were
based on a prevalence more than double that
estimated in the GBD study. Nevertheless, the
estimate of the associated burden in Victoria was
much lower because we use different DWs. The
GBD study used a uniform weight of 0.51 for the
EME region while in Victoria we modelled manic
episodes at a weight of 0.50, depressive episodes at
0.34 and the time between episodes at 0.14, resulting
in an average weight of 0.18 for the overall course of
illness. The very different estimates of the duration of
bipolar disorder between the two studies cannot
explain the large differences in burden estimates
because the incidence and duration are modelled on
prevalence data. Combinations of high incidence and
short duration or low incidence and long duration
that are consistent with the same prevalence figures
lead to marginal differences in burden estimates, as
YLD values are determined by the product of
incidence and duration.
Australian data indicated a higher prevalence of
PTSD in both sexes and of panic disorder in women,
but much lower prevalence of OCD. The latter was
probably overestimated in the GBD study, which
may have relied on survey results in which lay
interviewers used too broad criteria to diagnose this
disorder, as occurred in a Canadian study (41). In
contrast to the short durations for anxiety disorders
in the GBD study, we modelled them as chronic
conditions with periods of remission and relapses.
This led to very different YLD estimates, which were
also affected by the higher DWs. Our estimate of the
burden due to PTSD was higher, mostly because of
the higher prevalence. Our much lower estimate of
YLD for OCD was mostly influenced by the sixfold
lower prevalence estimate, the higher DW estimates
and the MHS-based estimates indicating that men
and women with OCD had 11% and 41%,
respectively, of the time symptom-free during the
course of their illness. Higher average DWs, an
estimate of 74% symptom-free periods during the
course of illness, and a higher observed prevalence
resulted in YLD estimates for panic disorder that
were considerably lower in men and women in
comparison with the estimates in the GBD study.
With the inclusion of three additional anxiety
disorders in adults (social phobia, generalized anxiety
disorder, and agoraphobia) and separation anxiety
disorder in childhood, the estimates in the Victoria
study for anxiety disorders were two-thirds higher
than in the GBD study.
Fig. 1. The burden of mental illness (years of life lost (YLL), years lost
due to disability (YLD), and disability-adjusted life years (DALYs)),
by disorder and sex, Victoria, Australia, 1996
Table 4. DALY rates per 1000 populationa for mental disorders in
Established Market Economies (EME) (1990) and Victoria, Australia
(1996)
Disorder Males Females
EME Victoria EME Victoria
All mental disorders 25.9 20.1 21.4 21.2
Affective disorders 8.2 6.7 12.7 9.0
Depression 6.0 5.3 10.7 7.7
Bipolar disorder 2.2 1.4 2.1 1.3
Anxiety disorders 2.4 4.3 3.6 6.0
Post-traumatic stress disorder 0.3 0.5 0.4 0.5
Obsessive–compulsive disorder 1.6 0.4 2.0 0.3
Panic disorder 0.6 0.2 1.1 0.6
Other anxiety disorders 0.0 3.2 0.0 4.6
Substance abuse 12.4 6.4 2.6 3.1
Alcohol dependence / harmful use 9.7 4.3 1.7 1.9
Drug dependence / harmful use 2.7 2.1 0.9 1.2
Schizophrenia 2.9 1.2 2.6 1.0
Other mental disorders 0.0 1.5 0.0 2.1
a Age-weighted and discounted DALYs, age-standardized to EME population, 1990.
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TheYLDestimates for schizophrenia inVictoria
were 60% lower than in the GBD study and reflected
lower estimates of prevalence, as other assumptions of
DWs and average duration were almost identical.
Discussion
The epidemiological assumptions underlying calcula-
tions of the disease burden caused by mental
disorders have not previously been examined. The
Australian burden of disease studies developed new
models for each of the mental disorders included in
the GBD study and made estimates for ten new
disease categories. Major differences in the under-
lying assumptions are outlined below.
. The use of Dutch DWs in the Australian studies
allowed the construction of disease models with
details by level of severity. In principle it is a great
improvement if estimates can be made explicitly
by level of severity, as each of themental disorders
shows considerable variation in severity. The use
of a single DW for a disease implicitly assumes an
average distribution of severity but does not give
the flexibility to adapt the weight to populations
with different severity distributions. The big
difficulty in our approach lay in matching
epidemiological data with the severity categories
for which DWs had been derived.
We decided not to derive DWs separately for
Australia in order to concentrate on the epidemio-
logical inputs to the burden of disease calculations.
This was made easier by the availability of the
Dutch weights covering the main sources of
disability in Australia. However, this left us with
the task of finding Australian data on mental
disorders to fit the Dutch severity levels as defined
by the six domains of the EQ5D+. Because the
MHS did not use the EuroQol, we mapped six
questions of the SF-12 to two domains of the
EuroQol in order to distinguish between levels of
severity. This was not a tested method but in
comparison to ICD-10 diagnoses it showed greater
distinction between levels of mild, moderate and
severe depression on all othermeasures of disability
in the survey. We then assumed that the same
method could distinguish between levels of
severity for the other disorders included in the
same survey. The very large contribution of mental
disorders to the overall burden of disease means
that there is a need for longitudinal studies of
people identified with a mental disorder in
community samples. This would allow a better
understanding to be obtained of the level of
disability suffered during the course of illness.
. Our revised disease models for anxiety disorders
and bipolar disorder as chronic conditions were
more in line with the literature than the durations
estimated in the GBD study. Follow-up studies of
peoplewith anxiety disorders justified our choice of
disease models of long duration with periods of
remission and relapses (34, 36, 42–43). As we had
only cross-sectional data on mental disorders in
Australia we used the ratio of one-year prevalence
and point prevalence to represent the proportion of
time during the chronic course of illness which was
Table 5. Estimates of prevalence, incidence and duration of mental disorders in the Global Burden
of Disease (GBD) study (1990) and Victoria (Vic) (1996)
Disorder Prevalence per Incidence per Duration in
1000a 1000a yearsb
GBD Vic GBD Vic GBD Vic
Males Major depression 0.9 1.0 16.3 10.9 0.56 0.73
Bipolar disorder 0.3 0.7 2.7 0.3 1.4–1.5 21–24
Panic disorder 0.3 0.3 3.8 0.2 0.75 10–16
Obsessive–compulsive disorder 1 0.1 6.2 0.2 1.6 4–7
Post-traumatic stress disorder 0.2 0.4 0.8 0.9 2.5 5
Schizophrenia 0.9 0.3 0.2 0.1 52–54 21–57
Alcohol dependence 3.9 2.7 24.0 12.9 1.5–1.7 4–5
Drug usec 0.8 2.0 7.7 4.3 1 3–13
Females Major depression 1.7 1.5 29.8 27.3 0.56 0.48
Bipolar disorder 0.3 0.7 2.6 0.3 1.4–1.5 21–24
Panic disorder 0.6 1.1 7.5 0.7 0.75 10–16
Obsessive–compulsive disorder 1.3 0.2 8.2 0.3 1.6 4–7
Post-traumatic stress disorder 0.3 0.6 1.3 1.1 2.5 5
Schizophrenia 0.9 0.3 0.2 0.1 52–54 21–57
Alcohol dependence 0.7 0.9 4.3 5.0 1.5–1.7 4–5
Drug useb 0.2 0.8 2.5 1.7 1 3–13
a Prevalences and incidences include an adjustment for comorbidity with other mental disorders.
b Ranges indicate variations in duration by age and sex .
c The GBD estimated prevalence of ‘‘dysfunctional and harmful drug use’’ as one category.
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spent with symptoms. Because the one-year
prevalence figures may be influenced by recall bias
it would be helpful to examine whether our
estimates of the proportion of time with symptoms
can be confirmed in longitudinal follow-up studies.
Similarly, there is uncertainty about the amount of
disability associated with alcohol dependence and
harmful use. On the advice of local alcohol experts,
we reduced YLD estimates for alcohol dependence
by assuming no disability for the proportion of
respondents not reporting disability on the SF-12.
That was an arbitrary decision made in relation to
alcohol dependence but not in relation to the other
mental disorders. Again this identifies a critical
need for follow-up data on people identified in
community surveys of mental disorders.
. Ignoring the common comorbidity between
mental disorders can lead to significant double
counting and overestimation of the burden of
disease. This is particularly important if a large
number ofmental disorders are included.Wewere
able to assess the occurrence of comorbidity
between five substance use disorders, six anxiety
disorders, two affective disorders and borderline
personality disorder from the results of a
representative Australian mental health survey.
The proportion of comorbidity ranged from 49%
in people identified with social phobia to 94% in
people with borderline personality disorder. The
latter figure raised the question as to whether
borderline personality disorder should be ex-
cluded from the burden of disease list of mutually
exclusive conditions and, instead, valued sepa-
rately as a risk factor for other mental disorders.
Our method of adjusting for comorbidity
assumed that each diagnosis contributed equally
to the overall level of disability. By capturing
severity separately from the SF-12 we were able to
allow for the fact that people with more than one
diagnosis were likely to experience greater
disability than people with only one of the
comorbid conditions. It is possible that in this
method some individuals with two or more
diagnoses contribute less YLD than a person with
the severest of these conditions. A laborious
procedure would be required in order to analyse
this on a case-by-case basis for each possible
combination of comorbid conditions. We decided
against this because we did not think it would
make a great difference to our overall results.
. Contrary to the sensitivity analyses for the GBD
study, which showed only a marginal difference
between results that were age-weighted and those
that were not, in Victoria age-weighting increased
the contribution of mental disorders to overall
DALYs by 57%. Thusmental disorders surpassed
cardiovascular diseases and cancer as a leading
cause of burden. Although the authors of the
GBD study mentioned that age-weighting pre-
ferentially gave more weight to mental disorders,
their overall conclusion that results were insensi-
tive to assumptions such as age-weighting did not
hold for the Victorian study. In the debate about
age-weighting in summary population health
measures it is important to note that its impact
may not be as slight as is commonly assumed.
Conclusions
Using different detailedmethods and data sources, the
Australian burden of disease studies have confirmed
that mental disorders are a leading cause of disease
burden in developed countries. Partly as a result of
methodological differences (including the use of
different weights, analysis of severity distributions
and adjustments for comorbidity) the Australian
estimates showed marked differences in comparison
to the results of the GBD study for particular
disorders. Lower severity weighting for alcohol
dependence in younger men together with differences
in prevalence resulted in lower burden in Australia.
Lower estimates of burden for major depression were
predominantly attributable to lower estimated sever-
ity. Despite using higher DWs, our estimates for OCD
were less than a quarter of the estimates of the GBD
study because of much lower prevalence estimates.
Much lower estimates of the burden for panic disorder
and higher estimates for PTSD were derived from
disease models with higher DWs, higher prevalence
estimates and adjustments for symptom-free periods
during the chronic course of illness.
Estimates of the total burden attributable to
anxiety disorders in Australia were almost twice as
high as in the GBD study because four additional
conditions were included in the Australian work.
We hope that our efforts to improve disease
modelling for mental disorders make a useful
contribution to disease burden methodology. We
believe that ourmodels are an improvement over those
used in the GBD study. There is still much scope for
further developments, particularly in themeasurement
of severity over the course of mental disorders and in
dealing with comorbidity. Full details of our calcula-
tions are available on the Internet (19). n
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Re´sume´
La charge de morbidite´ des troubles mentaux : comparaison entre les me´thodes
employe´es dans les e´tudes australiennes et dans l’e´tude sur la charge de
morbidite´ dans le monde
Les e´tudes sur la charge de morbidite´ effectue´es pour
l’ensemble de l’Australie et l’Etat de Victoria visent a`
examiner d’un œil critique les me´thodes utilise´es dans
l’e´tude sur la charge de morbidite´ dans le monde pour
estimer la charge repre´sente´e par les troubles mentaux.
Les e´tudes australiennes se servent d’une se´rie de
coefficients de ponde´ration des incapacite´s diffe´rents de
ceux employe´s dans l’e´tude pre´cite´e, permettant des
estimations plus de´taille´es selon le degre´ de gravite´. En
outre, on a effectue´ des ajustements pour tenir compte
de la comorbidite´ entre les troubles mentaux et on a
mesure´ un plus grand nombre de ces derniers ; par
ailleurs, on a rassemble´ les troubles lie´s a` la consomma-
tion de substances, les troubles anxieux et les troubles
bipolaires en un mode`le d’affections chroniques. En
conse´quence, les estimations australiennes ont montre´
des diffe´rences marque´es par rapport a` celles de
l’e´tude sur la charge de morbidite´ dans le monde. En
Australie, le nombre d’anne´es de vie ajuste´es sur
l’incapacite´ (DALY) infe´rieur de 48 % ainsi obtenu pour
la de´pendance alcoolique chez l’homme a e´te´ en partie
attribue´ a` des diffe´rences dans la pre´valence de cette
affection et en partie aux ajustements effectue´s pour
tenir compte d’une comorbidite´ avec d’autres troubles
mentaux, et a` une ponde´ration moins importante en
fonction de la gravite´. En Australie, les estimations plus
basses qui ont e´te´ faites du coefficient de ponde´ration de
l’incapacite´ en cas de de´pression majeure ont fait que
cette dernie`re repre´sente une charge infe´rieure de 36 %
chez les hommes et de 45 % chez les femmes, mais
l’inclusion de la dysthymie a diminue´ de moitie´ au moins
les e´carts observe´s. Bien que nous ayons utilise´ un
coefficient de ponde´ration de l’incapacite´ plus e´leve´, nos
estimations relatives aux troubles obsessionnels compul-
sifs ont repre´sente´ moins du quart de celles de
l’e´tude pre´cite´e du fait d’estimations de la pre´valence
bien infe´rieures. Des estimations bien plus faibles de la
charge de morbidite´ des troubles paniques et bien plus
e´leve´es de celle de l’e´tat de stress post-traumatique ont
e´te´ tire´es de mode`les de morbidite´ dans lesquels le
coefficient de ponde´ration de l’incapacite´ et les
estimations de la pre´valence e´taient plus e´leve´s et qui
comportaient des ajustements tenant compte des
pe´riodes asymptomatiques survenues au cours de la
maladie chronique. Les estimations relatives a` la charge
de morbidite´ totale attribuable aux troubles anxieux ont
e´te´ presque deux fois plus e´leve´es du fait que quatre
autres pathologies ont e´te´ incluses dans les e´tudes
australiennes. L’absence de ponde´ration en fonction de
l’aˆge dans les e´tudes australiennes a donne´ des
estimations conside´rablement plus faibles de la charge
de morbidite´ imputable aux troubles mentaux, par
comparaison avec les DALY ponde´re´s en fonction de
l’aˆge. Avec une telle ponde´ration, la part repre´sente´e par
les troubles mentaux dans l’ensemble des DALY a
progresse´ de 57 % dans l’Etat de Victoria et a de´passe´ en
importance les maladies cardio-vasculaires et le cancer.
L’absence de donne´es relatives au suivi des patients
pre´sentant un trouble mental identifie´s lors d’enqueˆtes
transversales constitue le proble`me le plus important
pour de´terminer plus pre´cise´ment la charge de morbidite´
des troubles mentaux. Si les ame´liorations apporte´es
dans les me´thodes pre´sente´es dans cet article consti-
tuent un progre`s important vers plus de pre´cision dans le
calcul de la charge de morbidite´ des troubles mentaux,
les perspectives de de´veloppement ulte´rieur restent
importantes.
Resumen
Carga de trastornos mentales: comparacio´n de los me´todos empleados en los
estudios de la carga de morbilidad en Australia y en el estudio sobre la Carga
Mundial de Morbilidad
Se estudio´ la carga de morbilidad en el conjunto de
Australia y en el Estado de Victoria de ese paı´s al objeto
de analizar crı´ticamente los me´todos empleados en el
estudio sobre la Carga Mundial de Morbilidad (CMM)
para estimar la carga de trastornos mentales. En los
estudios de Australia se utilizo´ un sistema de pondera-
cio´n de la discapacidad que, a diferencia del empleado
en el estudio CMM, permitı´a hacer estimaciones ma´s
detalladas en funcio´n del nivel de gravedad. Adema´s, se
hicieron ajustes para la comorbilidad entre trastornos
mentales, se midio´ un mayor nu´mero de trastornos
mentales, y se modelizaron como enfermedades cro´nicas
el abuso de sustancias, los trastornos de ansiedad y el
trastorno bipolar. En consecuencia, las estimaciones
australianas difirieron notablemente de las del estudio
CMM. Ası´, en Australia, en lo que concierne a la
dependencia del alcohol en los hombres, el hallazgo de
unas tasas de AVAD inferiores en un 48% podı´a
explicarse en parte por las diferencias en la prevalencia
observada de la afeccio´n y en parte por los ajustes para la
comorbilidad por otros trastornos mentales y la menor
ponderacio´n de la gravedad. Las ponderaciones ma´s
bajas de la discapacidad consideradas para la depresio´n
grave en Australia se tradujeron en una carga de
depresio´n grave inferior en un 36% entre los hombres y
en un 45% entre las mujeres, pero la inclusio´n de la
distimia redujo esas diferencias en ma´s de la mitad. Pese
a que ponderamos ma´s la discapacidad correspondiente,
nuestras estimaciones para los trastornos obsesivo-
compulsivos fueron inferiores a la cuarta parte de las
realizadas en el estudio CMM, debido a que se usaron
estimaciones mucho ma´s bajas de la prevalencia. Las
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muy inferiores cifras calculadas para la carga de trastorno
de pa´nico, y las superiores para el trastorno de estre´s
postrauma´tico, se obtuvieron a partir de modelos de las
enfermedades que introducı´an una mayor ponderacio´n
de la discapacidad, estimaciones mayores de la
prevalencia, y ajustes para los periodos asintoma´ticos
registrados durante la evolucio´n cro´nica de la enferme-
dad. Las estimaciones de la carga total de trastornos de
ansiedad fueron casi del doble debido a que en los
estudios australianos se incluyeron otras cuatro dolen-
cias. La ponderacio´n uniforme por edades utilizada en los
estudios australianos arrojo´ estimaciones considerable-
mente inferiores de la carga de trastornos mentales en
comparacio´n con los AVAD ponderados en funcio´n de la
edad. Con la ponderacio´n segu´n la edad, la cifra de
trastornos mentales en Victoria aumento´ en un 57%
como proporcio´n de los AVAD globales, superando a las
enfermedades cardiovasculares y al ca´ncer en orden de
importancia. La falta de datos de seguimiento sobre las
personas con trastornos mentales identificadas en las
encuestas transversales constituye el mayor obsta´culo
para poder determinar ma´s exactamente la carga de
trastornos mentales. Si bien las mejoras de los me´todos
presentados en este artı´culo son un paso importante
para calcular con ma´s exactitud la carga de trastornos
mentales, queda todavı´a amplio margen para perfeccio-
nar esas estimaciones.
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